Details of the Drug

General Information of Drug (ID: DMH4HEW)

Drug Name

rhenium-186

Synonyms

Rhenium-186; Rhenium Re-186; ZU7F1ET6TM; 14998-63-1; (~186~Re)Rhenium; UNII-ZU7F1ET6TM; 186Re; RHENIUM (186-RE); Rhenium, isotope of mass 186; DTXSID60933825; RHENIUM-186 [WHO-DD]; Q18882928

Indication

Disease Entry	ICD 11	Status	REF
Glioblastoma	2A00	Phase 1	[1]

Drug Type

Small molecule

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: Re
Canonical SMILES: [Re]
InChI: InChI=1S/Re/i1+0
InChIKey: WUAPFZMCVAUBPE-IGMARMGPSA-N

Cross-matching ID

PubChem CID: 161105
TTD ID: DB7W8H

References

1	ClinicalTrials.gov (NCT05460507) A Single Arm Open Label Study to Determine the Safety and Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Recurrence of Glioma in Patients Who Received a Prior Treatment With 186RNL. U.S.National Institutes of Health.